10.6084/m9.figshare.8982734.v1 Antonio Nicolucci Antonio Nicolucci Riccardo Candido Riccardo Candido Domenico Cucinotta Domenico Cucinotta Giusi Graziano Giusi Graziano Alberto Rocca Alberto Rocca Maria C. Rossi Maria C. Rossi Franco Tuccinardi Franco Tuccinardi Valeria Manicardi Valeria Manicardi Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice. Adis Journals 2019 Cardiovascular outcomes safety trials Electronic medical records Eligibility criteria Endocrinology Quality of care Real world data Sodium-Glucose cotransporter-2 inhibitors Type 2 diabetes 2019-08-09 11:19:06 Figure https://adisjournals.figshare.com/articles/figure/Generalizability_of_Cardiovascular_Safety_Trials_on_SGLT2_Inhibitors_to_the_Real_World_Implications_for_Clinical_Practice_/8982734 <p><strong>Provide enhanced digital features for this article</strong><br></p><p> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides</p>